Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$651M |
| 2 |
Charter Communications
CHTR
|
+$643M |
| 3 |
Parker-Hannifin
PH
|
+$606M |
| 4 |
Goldman Sachs
GS
|
+$534M |
| 5 |
FedEx
FDX
|
+$376M |
Top Sells
| 1 |
Biogen
BIIB
|
+$701M |
| 2 |
American Tower
AMT
|
+$665M |
| 3 |
Nike
NKE
|
+$595M |
| 4 |
AGN
Allergan plc
AGN
|
+$569M |
| 5 |
McDonald's
MCD
|
+$556M |
Sector Composition
| 1 | Technology | 18.72% |
| 2 | Consumer Discretionary | 17.48% |
| 3 | Healthcare | 13.38% |
| 4 | Communication Services | 12.13% |
| 5 | Financials | 11.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
WSFS Financial
WSFS
$3.18B
| $5.72M | 0.01% |
123,298
+2,430
| +2% | +$113K |
|
|
BOLD
502
DELISTED
Audentes Therapeutics, Inc
BOLD
| $5.48M | 0.01% |
299,656
+1,070
| +0.4% | +$19.6K |
|
503
Regenxbio
RGNX
$500M
| $5.42M | 0.01% |
292,268
+246
| +0.1% | +$4.56K |
|
|
CACB
504
DELISTED
Cascade Bancorp
CACB
| $5.29M | 0.01% |
651,388
+29,746
| +5% | +$242K |
|
|
FENX
505
DELISTED
Fenix Parts, Inc.
FENX
| $5.18M | 0.01% |
1,838,352
+31,028
| +2% | +$87.5K |
|
506
Amgen
AMGN
$148B
| $5.13M | 0.01% |
+35,067
| New | +$5.13M |
|
507
FB Financial Corp
FBK
$2.86B
| $5.06M | 0.01% |
194,990
+19,990
| +11% | +$519K |
|
508
IBM
IBM
$239B
| $5.03M | 0.01% |
31,683
+14,418
| +84% | +$2.29M |
|
|
TCP
509
DELISTED
TC Pipelines LP
TCP
| $4.83M | 0.01% |
82,145
+6,921
| +9% | +$407K |
|
|
LJPC
510
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $4.52M | 0.01% |
257,709
| – | – |
|
511
AT&T
T
$207B
| $4.23M | ﹤0.01% |
131,766
-1,220,292
| -90% | -$39.2M |
|
|
TRVN
512
DELISTED
Trevena, Inc.
TRVN
| $4.15M | ﹤0.01% |
1,129
+3
| +0.3% | +$11K |
|
513
PepsiCo
PEP
$195B
| $3.99M | ﹤0.01% |
38,125
+7,780
| +26% | +$814K |
|
514
MacroGenics
MGNX
$109M
| $3.86M | ﹤0.01% |
188,908
-6,203
| -3% | -$127K |
|
|
DFS
515
DELISTED
Discover Financial Services
DFS
| $3.85M | ﹤0.01% |
53,396
-856
| -2% | -$61.7K |
|
516
Ventas
VTR
$31.4B
| $3.77M | ﹤0.01% |
+60,322
| New | +$3.77M |
|
517
Baxter International
BAX
$12.5B
| $3.69M | ﹤0.01% |
83,107
+11,436
| +16% | +$507K |
|
|
NAK
518
Northern Dynasty Minerals
NAK
$454M
| $3.65M | ﹤0.01% |
1,763,422
-17,542
| -1% | -$36.3K |
|
519
Citizens Financial Group
CFG
$22.4B
| $3.61M | ﹤0.01% |
101,183
-30,064
| -23% | -$1.07M |
|
520
APA Corp
APA
$7.98B
| $3.58M | ﹤0.01% |
56,436
+52,123
| +1,209% | +$3.31M |
|
521
Stryker
SYK
$147B
| $3.51M | ﹤0.01% |
29,275
+18,635
| +175% | +$2.23M |
|
|
XL
522
DELISTED
XL Group Ltd.
XL
| $3.48M | ﹤0.01% |
+93,373
| New | +$3.48M |
|
523
Keurig Dr Pepper
KDP
$36.9B
| $3.39M | ﹤0.01% |
+37,333
| New | +$3.39M |
|
524
Tempest Therapeutics
TPST
$47.2M
| $3.34M | ﹤0.01% |
747
-266
| -26% | -$1.19M |
|
525
SPDR S&P Metals & Mining ETF
XME
$2.36B
| $3.24M | ﹤0.01% |
106,491
-572
| -0.5% | -$17.4K |
|